BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18342802)

  • 1. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage.
    Crowley RW; Medel R; Kassell NF; Dumont AS
    Drug Discov Today; 2008 Mar; 13(5-6):254-60. PubMed ID: 18342802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of current and future medical therapies for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Mocco J; Zacharia BE; Komotar RJ; Connolly ES
    Neurosurg Focus; 2006 Sep; 21(3):E9. PubMed ID: 17029348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm].
    Fandino J; Fathi AR; Graupner T; Jacob S; Landolt H
    Neurocirugia (Astur); 2007 Feb; 18(1):16-27. PubMed ID: 17393042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage.
    Suhardja A
    Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):110-6; quiz 2 p following 116. PubMed ID: 16265315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Kassell NF; Sasaki T; Colohan AR; Nazar G
    Stroke; 1985; 16(4):562-72. PubMed ID: 3895589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage.
    Keyrouz SG; Diringer MN
    Crit Care; 2007; 11(4):220. PubMed ID: 17705883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic research and treatment for cerebral vasospasm after subarachnoid hemorrhage: the present and future prospects].
    Nishizawa S; Zhang JH
    No Shinkei Geka; 2008 Feb; 36(2):121-33. PubMed ID: 18265695
    [No Abstract]   [Full Text] [Related]  

  • 8. Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage.
    Clark JF; Sharp FR
    J Cereb Blood Flow Metab; 2006 Oct; 26(10):1223-33. PubMed ID: 16467784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches.
    Kolias AG; Sen J; Belli A
    J Neurosci Res; 2009 Jan; 87(1):1-11. PubMed ID: 18709660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral vasospasm: current understanding.
    Rao GS; Muthuchellappan R
    Curr Opin Anaesthesiol; 2016 Oct; 29(5):544-51. PubMed ID: 27341013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic treatments of the vasospasm].
    Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endovascular treatment of cerebral vasospasm due to aneurysmal subarachnoid hemorrhage].
    Alcázar PP; González A; Romance A
    Med Intensiva; 2008 Nov; 32(8):391-7. PubMed ID: 19055932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic approaches to vasospasm in subarachnoid hemorrhage.
    Dorsch NW
    Curr Opin Crit Care; 2002 Apr; 8(2):128-33. PubMed ID: 12386513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of cerebral vasospasm following aneurysmal SAH.
    Rothoerl RD; Ringel F
    Neurol Res; 2007 Oct; 29(7):636-42. PubMed ID: 18173899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel treatments for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Lehmann E; Sagher O
    Acta Neurochir Suppl; 2008; 105():225-8. PubMed ID: 19066114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage.
    Topcuoglu MA; Singhal AB
    Expert Opin Drug Saf; 2006 Jan; 5(1):57-65. PubMed ID: 16370956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial heme metabolism and cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Suzuki H; Muramatsu M; Kojima T; Taki W
    Stroke; 2003 Dec; 34(12):2796-800. PubMed ID: 14657544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage.
    Weant KA; Ramsey CN; Cook AM
    Pharmacotherapy; 2010 Apr; 30(4):405-17. PubMed ID: 20334460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro model of aneurysmal subarachnoid hemorrhage: oxidation of unconjugated bilirubin by cytochrome oxidase.
    Loftspring MC; Wurster WL; Pyne-Geithman GJ; Clark JF
    J Neurochem; 2007 Sep; 102(6):1990-1995. PubMed ID: 17539918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.